Rural medical insurance can be reimbursed 80% if it is opened in Guangzhou outpatient department. In the Technical Specification for Tuberculosis Prevention and Control in China (2020 Edition), betaquinoline is regarded as the first choice for the treatment of multidrug-resistant tuberculosis, but as a new anti-tuberculosis drug, its cost is high, which brings great economic burden to patients. Patients only need to pay 20% of the drug fee, which reduces the economic burden and provides a guarantee for patients to complete treatment and eventually cure. Therefore, when betaquinoline is prescribed in Guangzhou outpatient department, 80% of rural medical insurance can be reimbursed.